We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Very Severe Chronic Fatigue Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01156922
Recruitment Status : Terminated (Difficulties in logistics handling the very severe patients (travel, hospital stay, follow-up))
First Posted : July 5, 2010
Last Update Posted : April 12, 2016
Information provided by (Responsible Party):
Haukeland University Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : April 2016
  Study Completion Date : April 2016